SCHEMBL17429661

SCHEMBL17429661

COC(=O)c1ccccc1CCc1cc(C)cc(C)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.59
▸ LMNA P02545 2/20 0.59
▸ KMT2A Q03164 2/20 0.47
▸ SCN1A P35498 4/20 0.45
▸ SCN2A Q99250 4/20 0.45
▸ SCN3A Q9NY46 4/20 0.45
▸ TSHR P16473 1/20 0.45
▸ HIF1A Q16665 1/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ HTT P42858 2/20 0.44
▸ MAPT P10636 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ CFTR P13569 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ ADRB2 P07550 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ SLC6A2 P23975 1/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ SLC6A3 Q01959 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17386156 0.90 ALDH1A1 (0.52) ALDH1A1LMNAKMT2ASCN1ASCN2A
SCHEMBL10360804 0.85 ALDH1A1 (0.77) ALDH1A1LMNAKMT2ATSHRHIF1A
SCHEMBL4068457 0.84 ALDH1A1 (0.66) ALDH1A1LMNAKMT2ASCN1ASCN2A
SCHEMBL31123666 0.84 ALDH1A1 (0.66) ALDH1A1LMNAKMT2ASCN1ASCN2A
SCHEMBL17429662 0.83 ALDH1A1 (0.54) ALDH1A1LMNAKMT2ATSHRHIF1A
SCHEMBL17385867 0.83 ALDH1A1 (0.50) ALDH1A1LMNAKMT2ATSHRHIF1A
SCHEMBL16672908 0.81 ALDH1A1 (0.66) ALDH1A1LMNAKMT2ATSHRHIF1A
SCHEMBL993441 0.79 ALDH1A1 (0.59) ALDH1A1LMNAKMT2ASCN1ASCN2A
SCHEMBL31123664 0.78 GAA (0.57) ALDH1A1LMNAKMT2APOLB
SCHEMBL4401163 0.77 ALDH1A1 (0.54) ALDH1A1LMNAKMT2ASCN1ASCN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 — — US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF GPR65, GPR119, GPR35 ALDH1A1 2066/4885LMNA 2845/4885KMT2A 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback